根据FDA不良事件报告系统数据,对药物诱导的乳腺癌进行了更新的综合药监测研究
Ziran Qiu1, Xinyu Liu2, Wenqing Cao1
1Department of Breast and Thyroid Surgery, Loudi Central Hospital, Loudi, 417000, China.
Current medicinal chemistry
|January 9, 2026
概括
这项研究分析了FDA不良事件报告,以确定乳腺癌药物风险. 某些疗法,如拉帕蒂尼布 (lapatinib) 和特拉斯图祖马布 (trastuzumab) 显示了更高的不良事件报告率,突出了需要仔细监测和个性化治疗决策的需要.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 了解乳腺癌 (BC) 治疗中的药物特异性风险概况对于监管和临床决策至关重要.
- 现有的知识差距需要对不良事件数据进行全面分析.
研究的目的:
- 分析FDA的不良事件报告系统 (FAERS) 数据库的乳腺癌 (BC) 药物安全性.
- 确定与较高比例的不良事件报告相关的特定药物,并评估它们的风险概况.
主要方法:
- 使用FAERS数据 (2004-2024) 的回顾性研究.
- 数据清理,药品名称标准化.
- 统计分析包括比例失衡和报告几率比率 (ROR).
主要成果:
- 在BC药物之间,在不良反应报告中发现了显著的差异.
- 特拉斯图祖马布,拉帕蒂尼布和某些内分泌疗法显示了更高的不良事件报告和ROR值.
- 心脏毒性,骨质疏松症,卵巢功能障碍和免疫并发症是关键的不良反应.
结论:
- FAERS数据分析显示,在BC疗法中,药物诱导的不良事件存在显著差异.
- 针对性治疗 (拉帕蒂尼布,富尔韦斯特兰特,莱特,里博西基利布) 和HER2阳性BC治疗 (特拉斯图祖马布) 需要谨慎监测.
- 根据不同的药物风险概况,针对BC患者进行个性化风险效益评估是必不可少的.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
FDA Approved Drugs: Changes to Approved Drugs
239
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
239
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196


